Surgical Management of Posterior Tibial Plateau Fractures (Proxtib)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
-
Brussel, Belgium, 1090
- UZ Brussel
-
Leuven, Belgium, 3000
- UZ Leuven
-
-
-
-
-
Rotterdam, Netherlands, 3015
- Erasmus MC Rotterdam
-
-
-
-
-
Luzern, Switzerland, 6000
- Luzerner Kantonsspital Luzern
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Tibial plateau fracture with involvement of posterior proximal tibial plateau (according to revised three-column classification), requiring osteosynthesis
Exclusion Criteria:
- Absent contact information
- living abroad and cannot participate in the follow-up visits
- non-functional leg prior to treatment/injury
- pathological fractures
- bilateral fractures
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Subjective evaluation: outcome
Time Frame: 1 year
|
Total Knee injury and Osteoarthritis Outcome Score (KOOS) questionnaire to measure patient's opinion about his or her knee and the associatede problems.
|
1 year
|
|
Subjective evaluation: pain
Time Frame: 1 year
|
Visual analogue scale (VAS) to indicate the daily pain level.
|
1 year
|
|
Clinical evaluation
Time Frame: 1 year
|
Recording of demographic and fracture-related characteristics.
|
1 year
|
|
Radiographic evaluation
Time Frame: 1 year
|
Parameters derived from CT and RX.
|
1 year
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Complications
Time Frame: 1-7 days post-operatively, 8 weeks, 12 weeks, 6 months, 9 months, 1 year
|
Recording of complications: infection, nonunion, wound related problems, implant related complaints, compartment syndrome, neurological disorder, muscle atrophy and deep vein thrombosis.
|
1-7 days post-operatively, 8 weeks, 12 weeks, 6 months, 9 months, 1 year
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Harm Hoekstra, Prof. MD, UZ Leuven
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- S60860
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.